The Priority Review

Tag

Vascular Therapies

1 story

  1. Clinical trials

    Vascular Therapies posts results of Phase 3 ACCESS 2 trial of Sirogen in ESRD patients

    The ACCESS 2 trial, a Phase 3 study with 136 participants, evaluated the Sirolimus eluting Collagen implant (Sirogen) in patients undergoing arteriovenous fistula surgery. Results were first posted on ClinicalTrials.gov on October 6, 2026, after the study's primary completion on March 18, 2025.